2020
DOI: 10.3389/fimmu.2020.01435
|View full text |Cite
|
Sign up to set email alerts
|

Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism

Abstract: Therapeutic corticosteroids have an immunosuppressive function involving several pathways, including lymphocytopenia and hypogammaglobulinemia. While these effects have been well-described in patients that received corticosteroids for therapeutic reasons, the effects of endogenous corticosteroids on the immune system are less well-understood. Here, we describe a 21-year old patient with hypercortisolism due to an ACTH producing thymic tumor. In this patient, we observed a decrease in some of the immunoglobulin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…Concomitant splenectomy may influence the patients’ immune capacity. Additionally, the patients may suffer from hypogammaglobulinemia, which is caused by endogenous or therapeutic hypercortisolism and leads to a decreased immunoglobulin G (IgG) production and increased IgG catabolism [ 9 , 10 ]. The low level of IgG may persist even after discontinuation of steroid treatment [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…Concomitant splenectomy may influence the patients’ immune capacity. Additionally, the patients may suffer from hypogammaglobulinemia, which is caused by endogenous or therapeutic hypercortisolism and leads to a decreased immunoglobulin G (IgG) production and increased IgG catabolism [ 9 , 10 ]. The low level of IgG may persist even after discontinuation of steroid treatment [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…The critical role of hypothalamic-pituitaryadrenal axis dysregulation and altered cortisol secretion in the manifestation of MDD is well established (Krishnan and Nestler, 2008). Physiological states associated with high levels of circulating cortisol, such as hypercortisolism (Sarcevic et al, 2020) or treatment of patients with corticosteroid-based interventions, shifts serum antibody profiles relative to healthy controls (Griggs et al, 1972;Settipane et al, 1978). As well, neuronal surface autoantibody expression has been implicated in a number of neuropsychiatric conditions, MDD included (Zong et al, 2017).…”
Section: Evidence Of Immune Impacts On the Development And Persistenc...mentioning
confidence: 99%